伟思医疗
(688580)
| 流通市值：29.49亿 | | | 总市值：29.49亿 |
| 流通股本：9577.13万 | | | 总股本：9577.13万 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 291,757,867.37 | 191,578,926.4 | 87,670,336.46 | 462,223,134.18 |
| 营业收入 | 291,757,867.37 | 191,578,926.4 | 87,670,336.46 | 462,223,134.18 |
| 二、营业总成本 | 231,830,532.26 | 154,659,278.69 | 72,378,521.4 | 347,039,683.14 |
| 营业成本 | 84,368,036.05 | 56,299,944.17 | 26,139,839.8 | 130,514,365.89 |
| 税金及附加 | 3,972,320.64 | 2,635,903.41 | 1,278,310.74 | 5,725,398.05 |
| 销售费用 | 78,091,594.75 | 50,300,484.1 | 22,218,305.11 | 123,635,441.34 |
| 管理费用 | 33,635,402.69 | 24,142,713.93 | 12,722,391.99 | 47,491,101.06 |
| 研发费用 | 39,929,327.9 | 28,731,566.97 | 15,427,799.83 | 57,654,199.29 |
| 财务费用 | -8,166,149.77 | -7,451,333.89 | -5,408,126.07 | -17,980,822.49 |
| 其中:利息费用 | 965,574.45 | 643,716.3 | 321,858.15 | 1,318,536.24 |
| 其中:利息收入 | 9,146,676.08 | 8,113,856.31 | 5,709,147.07 | 19,315,486.55 |
| 加:公允价值变动收益 | - | - | - | -964,049.74 |
| 加:投资收益 | 8,238,504.93 | 5,003,107.97 | 1,133,776.46 | 10,579,946.08 |
| 资产处置收益 | 434.96 | 434.96 | - | -2,113.24 |
| 信用减值损失(新) | -133,334.87 | -139,747.28 | -11,288.86 | -2,188,349.52 |
| 其他收益 | 16,327,300.68 | 11,074,992.37 | 6,209,111.81 | 25,833,405.17 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 84,360,240.81 | 52,858,435.73 | 22,623,414.47 | 148,442,289.79 |
| 加:营业外收入 | 143,811.99 | 118,008.57 | 102,047.79 | 1,611,693.02 |
| 减:营业外支出 | 28,529.64 | 28,529.64 | - | 42,293.84 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 84,475,523.16 | 52,947,914.66 | 22,725,462.26 | 150,011,688.97 |
| 减:所得税费用 | 6,309,246.81 | 3,327,508.5 | 972,308.93 | 13,753,059.95 |
| 六、净利润 | 78,166,276.35 | 49,620,406.16 | 21,753,153.33 | 136,258,629.02 |
| 持续经营净利润 | 78,166,276.35 | 49,620,406.16 | 21,753,153.33 | 136,258,629.02 |
| 归属于母公司股东的净利润 | 78,166,276.35 | 49,620,406.16 | 21,753,153.33 | 136,258,629.02 |
| (一)基本每股收益 | 0.82 | 0.52 | 0.32 | 2 |
| (二)稀释每股收益 | 0.82 | 0.52 | 0.32 | 1.99 |
| 九、综合收益总额 | 78,166,276.35 | 49,620,406.16 | 21,753,153.33 | 136,258,629.02 |
| 归属于母公司股东的综合收益总额 | 78,166,276.35 | 49,620,406.16 | 21,753,153.33 | 136,258,629.02 |
| 公告日期 | 2024-10-25 | 2024-08-29 | 2024-04-26 | 2024-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |